Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

Resource Type

CF Research News

Authors

Bastien Misgault, Eva Chatron, Quitterie Reynaud, Sandrine Touzet, Michel Abely, Laurent Melly, Stéphane Dominique, Françoise Troussier, Olivia Ronsin-Pradel, Michèle Gerardin, Julie Mankikian, Laure Cosson, Raphael Chiron, Leila Bounyar, Michel Porzio
Isabelle Durieu, Laurence Weiss, Romain Kessler, Laurence Kessler

References

J Cyst Fibros . 2020 Mar 19;S1569-1993(20)30073-4. doi: 10.1016/j.jcf.2020.03.002.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR corrector and potentiator [3]
Glucose tolerance abnormalities [4]
OGTT [5]

Date

Tuesday, May 19, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/effect-one-year-lumacaftor-ivacaftor-treatment-glucose-tolerance

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-19-00448R2_FINAL_Kessler_300720.pdf [2] https://pubmed.ncbi.nlm.nih.gov/32201160/ [3] https://www.ecfs.eu/research-article-keywords/cftr-corrector-and-potentiator [4] https://www.ecfs.eu/research-article-keywords/glucose-tolerance-abnormalities [5] https://www.ecfs.eu/research-article-keywords/ogtt [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines